Crafting a shared vision CVM partnering with mural artist Tia Richardson to create community artwork ‘A perfect storm’ Cross-hospital collaboration helps a young French bulldog overcome a barrage of severe gastrointestinal problems that nearly turned deadly Care beyond borders CVM group joins an international volunteer effort in Mazunte, Mexico, that seeks to save sea turtles by keeping community dog populations in check News archive CategoryAll newsAlumniAwardsCollege wideCOVID-19EducationFacultyResearchServiceStudents TypeVBSVetmed Small steps lead to big discoveries Hypertriglyceridemia is common in both miniature schnauzers and people, but the major genetic variants at play are likely very different. Species without borders: How collaboration could improve management of aquatic invasives New LCCMR-supported research models the most effective and efficient approaches to watercraft inspections. Mice among men Rodents often share spaces—and diseases—with humans. Research reveals how the microbes they harbor depend on where a mouse lives. Envisioning a future without brain tumors Susan Arnold’s research brings new inspiration to a legacy of progress at the Canine Brain Tumor Program. Advancing into the unknown An expert panel discusses opportunities and concerns surrounding ethical AI use in research. Spring 2024 Graduate Seminar Highlights Presentation highlights from the Spring 2024 Graduate Seminar Series. New research into Thoroughbred bone fractures aims at avoiding catastrophe on the racetrack The genetic factors related to fracture risk have been difficult to isolate—until now. CVM researchers receive grant to study why kidney stones form in cats Their work has implications for our understanding of chronic kidney disease, too. Discovering novel treatments for HIV and Prion disease with the Skinner lab The Skinner Lab team graciously agreed to sit down to answer interview questions about their HIV and Prion Disease research. Newly funded study aimed at reducing risk, improving interventions for canine lymphoma The study brings together researchers from the U of M CVM, Masonic Cancer Center, and Medical School. Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
‘A perfect storm’ Cross-hospital collaboration helps a young French bulldog overcome a barrage of severe gastrointestinal problems that nearly turned deadly
Care beyond borders CVM group joins an international volunteer effort in Mazunte, Mexico, that seeks to save sea turtles by keeping community dog populations in check
Small steps lead to big discoveries Hypertriglyceridemia is common in both miniature schnauzers and people, but the major genetic variants at play are likely very different.
Species without borders: How collaboration could improve management of aquatic invasives New LCCMR-supported research models the most effective and efficient approaches to watercraft inspections.
Mice among men Rodents often share spaces—and diseases—with humans. Research reveals how the microbes they harbor depend on where a mouse lives.
Envisioning a future without brain tumors Susan Arnold’s research brings new inspiration to a legacy of progress at the Canine Brain Tumor Program.
Advancing into the unknown An expert panel discusses opportunities and concerns surrounding ethical AI use in research.
Spring 2024 Graduate Seminar Highlights Presentation highlights from the Spring 2024 Graduate Seminar Series.
New research into Thoroughbred bone fractures aims at avoiding catastrophe on the racetrack The genetic factors related to fracture risk have been difficult to isolate—until now.
CVM researchers receive grant to study why kidney stones form in cats Their work has implications for our understanding of chronic kidney disease, too.
Discovering novel treatments for HIV and Prion disease with the Skinner lab The Skinner Lab team graciously agreed to sit down to answer interview questions about their HIV and Prion Disease research.
Newly funded study aimed at reducing risk, improving interventions for canine lymphoma The study brings together researchers from the U of M CVM, Masonic Cancer Center, and Medical School.